[18F]AlF-ETN

N/A

Report date: 2025/11/20 13:28:21
NME

Base Information

Drug Name[18F]AlF-ETN
Drug Alias Name[18F]AlF-ETN
ClassificationDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agent +[5] 
Mechanisms of ActionEphrin type-A receptor 2 modulators
TargetsEphrin type-A receptor 2
Therapy Area/IndicationsSolid tumoursProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesCapital Medical UniversityYunnan Baiyao Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCancer Hospital Of Chinese Academy Of Medical SciencesCapital Medical UniversityYunnan Baiyao Group Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A